Science journalists have been asked to follow the processes that lead to the manufacturing of pharmaceutical products instead of announcing the commencement and availability of products on the market.The call was made by Mr Paul Kemp, Chief Executive Officer of Intercytex Limited, UK-based Pharmaceutical firm, on Wednesday June 26, 2013.He said journalists were usually “hysterical” in reporting on the beginning and finished product without taking the general public through the development processes of drugs and medicines.Mr Kemp was speaking on “Media, Industry and Academia - Conflict, Collaboration and the Public Interest in Medical Sciences Advances”, at the Eighth World Conference of Science Journalists in Helsinki, Finland.The conference is on the theme: “Critical Questioning in the Public Sphere,” and was attended by more than 800 participants from 77 countries.Mr Kemp said consistency of reportage “provides good background and eliminates all doubts, risks and challenges in the production line, guaranteeing quality assurance before the final product even gets to the market”.Professor Ulf Landergren, Immunologist and Genetics of Uppsala University, Sweden, said the frosty relationship between medical practitioners, industry players and the media was a non-starter. He said the media was indispensable in issues concerning the medical sciences, and advocated for closer relationships.“These new relationships should urge academia to break hard to understand jargons in the medical sciences for easy communication and acceptance by the public,” Prof. Landergren said.Ms Dominique Leglu, Editor in Chief of Science et Avenir, a French publication, said journalism strives on controversy.She said the work of science reporters could "be easier when for instance two schools of thought contest whether genetically modified organisms products are wholesome or not".Ms Leglu said science is not fiction but duels on the reality and intrinsic evidence.She urged scholars or scientists to engage industry so that they could make more ‘breakthroughs’ in the sciences, especially medical sciences.Mr Clive Cookson, Science Editor of Financial Times, UK, noted that the relation between the media and academia was harsh but subtle and called for a change.